PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ADCT vs. GERN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ADCT and GERN is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

ADCT vs. GERN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADC Therapeutics SA (ADCT) and Geron Corporation (GERN). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%AugustSeptemberOctoberNovemberDecember
-34.98%
-18.80%
ADCT
GERN

Key characteristics

Sharpe Ratio

ADCT:

0.17

GERN:

0.61

Sortino Ratio

ADCT:

1.21

GERN:

2.42

Omega Ratio

ADCT:

1.15

GERN:

1.28

Calmar Ratio

ADCT:

0.21

GERN:

0.70

Martin Ratio

ADCT:

0.55

GERN:

4.74

Ulcer Index

ADCT:

36.47%

GERN:

14.31%

Daily Std Dev

ADCT:

119.90%

GERN:

110.45%

Max Drawdown

ADCT:

-99.08%

GERN:

-98.65%

Current Drawdown

ADCT:

-96.10%

GERN:

-94.63%

Fundamentals

Market Cap

ADCT:

$196.28M

GERN:

$2.03B

EPS

ADCT:

-$2.39

GERN:

-$0.32

Total Revenue (TTM)

ADCT:

$70.27M

GERN:

$29.48M

Gross Profit (TTM)

ADCT:

$62.80M

GERN:

$28.46M

EBITDA (TTM)

ADCT:

-$111.84M

GERN:

-$187.93M

Returns By Period


ADCT

YTD

0.00%

1M

-17.77%

6M

-42.82%

1Y

19.88%

5Y*

N/A

10Y*

N/A

GERN

YTD

0.00%

1M

-14.08%

6M

-15.11%

1Y

67.77%

5Y*

21.68%

10Y*

0.71%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ADCT vs. GERN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ADC Therapeutics SA (ADCT) and Geron Corporation (GERN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ADCT, currently valued at 0.17, compared to the broader market-4.00-2.000.002.000.170.61
The chart of Sortino ratio for ADCT, currently valued at 1.21, compared to the broader market-4.00-2.000.002.004.001.212.42
The chart of Omega ratio for ADCT, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.28
The chart of Calmar ratio for ADCT, currently valued at 0.21, compared to the broader market0.002.004.006.000.211.29
The chart of Martin ratio for ADCT, currently valued at 0.55, compared to the broader market0.005.0010.0015.0020.0025.000.554.74
ADCT
GERN

The current ADCT Sharpe Ratio is 0.17, which is lower than the GERN Sharpe Ratio of 0.61. The chart below compares the historical Sharpe Ratios of ADCT and GERN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00AugustSeptemberOctoberNovemberDecember
0.17
0.61
ADCT
GERN

Dividends

ADCT vs. GERN - Dividend Comparison

Neither ADCT nor GERN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ADCT vs. GERN - Drawdown Comparison

The maximum ADCT drawdown since its inception was -99.08%, roughly equal to the maximum GERN drawdown of -98.65%. Use the drawdown chart below to compare losses from any high point for ADCT and GERN. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember
-96.10%
-30.45%
ADCT
GERN

Volatility

ADCT vs. GERN - Volatility Comparison

ADC Therapeutics SA (ADCT) has a higher volatility of 74.52% compared to Geron Corporation (GERN) at 10.71%. This indicates that ADCT's price experiences larger fluctuations and is considered to be riskier than GERN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%AugustSeptemberOctoberNovemberDecember
74.52%
10.71%
ADCT
GERN

Financials

ADCT vs. GERN - Financials Comparison

This section allows you to compare key financial metrics between ADC Therapeutics SA and Geron Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab